Associated Papers
Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors.
Ohshima K et al.
Cancer Science, 2019
31553483 (PubMed )
Supplement: CAS-110-3821-s008.xlsx › Table_S2
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S et al.
Oncotarget, 2016
Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.
Vila L et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2009
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutations.
Kiesel H et al.
Cancer Biology & Therapy, 2009
Interstitial cells of Cajal do not harbor c-kit or PDGFRA gene mutations in patients with sporadic gastrointestinal stromal tumors.
Nakajima T et al.
Journal of Gastroenterology, 2009
c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.
Willmore-Payne C et al.
Cancer, 2005
Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
Willmore C et al.
American Journal of Clinical Pathology, 2004
KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
Holst VA et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 1999
Select a paper to view details